LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
LKFT
85 hedge funds and large institutions have $494M invested in Lakefront Biotherapeutics American Depositary Shares in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
25% less capital invested
Capital invested by funds: $660M → $494M (-$166M)
86% less call options, than puts
Call options by funds: $230K | Put options by funds: $1.66M
Holders
85
Holding in Top 10
4
Calls
$230K
Puts
$1.66M
Top Buyers
| 1 | +$11.9M | |
| 2 | +$3.8M | |
| 3 | +$3.76M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$2.63M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.59M |
Top Sellers
| 1 | -$36.5M | |
| 2 | -$8.35M | |
| 3 | -$3.68M | |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$1.96M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.73M |